Boston Scientific · 1 month ago
Quality Technician II - 2nd Shift
Boston Scientific is a leader in medical science committed to solving health industry challenges. The Quality Technician II role involves providing quality support to product development and manufacturing, focusing on quality methodologies from development through commercialization.
Health CareMedicalMedical Device
Responsibilities
Perform testing associated with product testing
Participate in and follow directions with regard to basic statistical analysis
Assist engineers in failure analysis and CAPA activities
Participate in continuous improvement projects
Assist with quality issues and quality metrics-related activities
Assist with product failure analysis
Perform testing, gather data, and analyze results of product testing and process monitoring
Assist with audit-related activities
Assist with CAPA activities
Assist in creating, validating, and maintaining data files and forms
Use documentation systems to research information and generate Change Requests
Assist in developing and qualifying test methods, data sheets, test fixtures, and testing equipment
Assist in the investigation and disposition of nonconforming materials, designs and/or systems
Review device history records (DHR) and acceptance records to ensure all activities in the Device Master Record (DMR) have been performed and approved
Update databases and spreadsheets used to track, monitor, and report department activities
Use the inventory and traceability management systems to transact and research material
Communicate with a wide variety of BSC personnel in and outside of the plant
Qualification
Required
2 years of experience with a high school diploma/degree/equivalent
Preferred
Proficient in NCEPs
Technical writing skills
Company
Boston Scientific
Boston Scientific is a medical technology company that designs and develops medical devices to diagnose and treat a wide range of condition.
Funding
Current Stage
Public CompanyTotal Funding
$10.02B2025-02-21Post Ipo Debt· $1.58B
2024-02-22Post Ipo Debt· $2.17B
2022-03-04Post Ipo Debt· $3.28B
Recent News
BioWorld Financial Watch
2025-12-25
2025-12-12
2025-12-11
Company data provided by crunchbase